0000927066-19-000120.txt : 20190621 0000927066-19-000120.hdr.sgml : 20190621 20190621184637 ACCESSION NUMBER: 0000927066-19-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190619 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waters Kathleen Alyce CENTRAL INDEX KEY: 0001640409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 19912767 MAIL ADDRESS: STREET 1: C/O HEALTH NET, INC. STREET 2: 21650 OXNARD STREET CITY: WOODLAND HILLS STATE: CA ZIP: 91367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wf-form4_156115718275765.xml FORM 4 X0306 4 2019-06-19 0 0000927066 DAVITA INC. DVA 0001640409 Waters Kathleen Alyce C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Legal Officer Common Stock 2019-06-19 4 A 0 33148 0 A 59663 D Common Stock 2019-06-19 4 F 0 8425 0 D 51238 D Stock Appreciation Rights 52.41 2019-06-20 4 A 0 80000 0 A 2024-06-20 Common Stock 80000.0 80000 D Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 28, 2018, in which 16,574 shares vested on June 19, 2019, and the remaining 16,574 vest on December 19, 2020. Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of 16,574 shares as described in footnote 1 above. The stock appreciation rights are scheduled to vest 50% on each of June 20, 2022 and June 20, 2023, respectively, subject to the terms and conditions of the applicable award agreement. /s/ James K. Hilger, Attorney-in-Fact 2019-06-21